JD Health International (JDHIF) Stock Price, News & Analysis

Company Overview

JD Health International, Inc. (OTCMKTS:JDHIF) is the publicly traded arm of JD.com dedicated to providing digital healthcare solutions. Founded in 2014 and headquartered in Beijing, it leverages the parent company’s logistics and technology infrastructure to deliver a broad suite of online medical services and products. The company’s platform connects patients with licensed physicians for virtual consultations, health management, and personalized care, while also sourcing and selling pharmaceutical, wellness, and personal care items directly to consumers.

The firm’s core offerings include an e-commerce pharmacy that stocks prescription and over-the-counter medications, traditional Chinese medicines, and health supplements. Through its mobile app and web portal, JD Health enables users to access telemedicine consultations, electronic prescriptions, and home delivery services. The company also provides enterprise-level solutions such as medical claims processing, health data analytics, and technology-driven supply chain management for hospitals, insurers, and healthcare providers.

JD Health primarily serves customers in Mainland China, leveraging an extensive cold-chain and last-mile delivery network inherited from its parent, JD.com. This infrastructure supports same-day or next-day delivery in many urban centers, and same-hour delivery in select cities. The company has also expanded certain services into Hong Kong and maintains strategic partnerships with domestic pharmaceutical manufacturers and regional healthcare institutions.

As a subsidiary majority-owned by JD.com, JD Health operates as an independent entity with its own corporate governance and leadership team. It became publicly listed on the Hong Kong Stock Exchange in December 2020 and its American Depositary Receipts trade over the counter in the United States under the symbol JDHIF. The company continues to invest in expanding its digital health ecosystem, aiming to integrate artificial intelligence and big-data capabilities into preventative care and chronic disease management.

Key Stats

• Today's Range: $6.27 to $6.27
• 50-Day Range: $3.23 to $6.27
• 52-Week Range: $3.23 to $6.27
• Volume: 3,955 shs
• Average Volume: 3,477 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

JDHIF Stock Analysis - Frequently Asked Questions

How have JDHIF shares performed this year?

JD Health International's stock was trading at $3.1250 at the beginning of the year. Since then, JDHIF stock has increased by 100.7% and is now trading at $6.2705.

How do I buy shares of JD Health International?

Shares of JDHIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/18/2025
• Next Earnings (Estimated): 8/13/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical Retailers
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:JDHIF
• CIK: N/A
• Web: ir.jdhealth.com
• Phone: N/A
• Fax: N/A
• Employees: 3,177
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A